[
    [
        {
            "time": "2021-05-07",
            "original_text": "欧普康视(300595.SZ)拟定增募资不超过21.96亿元用于社区化眼视光服务终端建设项目等",
            "features": {
                "keywords": [
                    "欧普康视",
                    "定增",
                    "募资",
                    "21.96亿元",
                    "社区化眼视光服务终端"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "欧普康视(300595.SZ)拟定增募资不超过21.96亿元用于社区化眼视光服务终端建设项目等",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2021-05-07",
            "original_text": "欧普康视拟募资约21.96亿元 面临现有产品结构单一可能导致的风险 经营问题",
            "features": {
                "keywords": [
                    "欧普康视",
                    "募资",
                    "21.96亿元",
                    "产品结构单一",
                    "风险",
                    "经营问题"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "欧普康视拟募资约21.96亿元 面临现有产品结构单一可能导致的风险 经营问题",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "2021-05-07",
            "original_text": "欧普康视：拟定向增发募资不超过约21.96亿元",
            "features": {
                "keywords": [
                    "欧普康视",
                    "定增",
                    "募资",
                    "21.96亿元"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "欧普康视：拟定向增发募资不超过约21.96亿元",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 10
            }
        },
        {
            "time": "2021-05-07",
            "original_text": "欧普康视：最近五年公司受处罚或监管及整改情况 其他违规处罚",
            "features": {
                "keywords": [
                    "欧普康视",
                    "处罚",
                    "监管",
                    "整改",
                    "违规"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "欧普康视：最近五年公司受处罚或监管及整改情况 其他违规处罚",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 5,
                "Source_Recency": 10
            }
        },
        {
            "time": "2021-05-07",
            "original_text": "医疗器械板块2020&2021Q1总结：抗疫需求持续释放 医疗新基建带动新增长",
            "features": {
                "keywords": [
                    "医疗器械",
                    "抗疫需求",
                    "医疗新基建",
                    "新增长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医疗器械板块2020&2021Q1总结：抗疫需求持续释放 医疗新基建带动新增长",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        }
    ]
]